" class="no-js "lang="en-US"> University of Southampton - Medtech Alert
Tuesday, July 29, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
University of Southampton | Pharmtech Focus

University of Southampton

About University of Southampton

University of Southampton

Related Story

Cardiovascular

 Obesity Linked to Damaging Changes in Failing Hearts | Pharmtech Focus

Obesity Linked to Damaging Changes in Failing Hearts

June 9 2022

Obesity is linked to changes in the structure and pumping action of the heart before […]

Artificial Intelligence

 my mhealth and University of Southampton announced as Round 2 Winner of The Artificial Intelligence in Health and Care Award | Pharmtech Focus

my mhealth and University of Southampton announced as Round 2 Winner of The Artificial Intelligence in Health and Care Award

June 24 2021

my mhealth Limited and the University of Southampton have been announced as a winner of […]